ABSTRACT
In Chapter 9, “Spice Drugs, Synthetic Cannabinoids, and ‘Spiceophrenia’”, Duccio Papanti, Laura Orsolini, John M. Corkery, and Fabrizio Schifano look at the evolution of the Spice market since 2004. They explore the epidemiology, use profiles, pharmacology, and toxicity, and desired and adverse effects, among other important clinical features. Attention is given to the clinical presentations and management of ‘spiceophrenia’.
